beta-glycerophosphoric acid has been researched along with alendronate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Hirafuji, M; Igarashi, K; Mitani, H; Shinoda, H | 1 |
| Jono, S; Mori, K; Morii, H; Nishizawa, Y; Shioi, A | 1 |
| Barbier, A; Baslé, MF; Chappard, D; Filmon, R | 1 |
| Boraie, N; Nafee, N; Zewail, M | 1 |
4 other study(ies) available for beta-glycerophosphoric acid and alendronate
| Article | Year |
|---|---|
Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1.
Topics: Alendronate; Alkaline Phosphatase; Animals; Calcification, Physiologic; Calcium; Cell Line; Clodronic Acid; Culture Media; Dinoprostone; Diphosphonates; DNA; Glycerophosphates; Mice; Osteoblasts; Pamidronate | 1997 |
Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification.
Topics: Alendronate; Animals; Blotting, Northern; Calcinosis; Calcium; Calcium-Binding Proteins; Cattle; Cells, Cultured; Etidronic Acid; Extracellular Matrix Proteins; Gene Expression; Glycerophosphates; Kinetics; Matrix Gla Protein; Models, Biological; Muscle, Smooth, Vascular; RNA, Messenger; Vascular Diseases | 1998 |
Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: a composite biomaterial allowing in vitro studies of bisphosphonates on the mineralization process.
Topics: Alendronate; Alkaline Phosphatase; Biocompatible Materials; Bone and Bones; Calcium; Cartilage; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Fetus; Glycerophosphates; Humans; Microscopy, Electron; Microscopy, Electron, Scanning; Models, Chemical; Organophosphonates; Polyhydroxyethyl Methacrylate; Tibia; Time Factors; Zinc | 2000 |
Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Glycerophosphates; Hydrogels; Injections, Subcutaneous; Microscopy, Electron, Scanning; Osteoporosis; Proof of Concept Study; Rats; Spectroscopy, Fourier Transform Infrared | 2018 |